Part Details | EMTRICITABINE AND T
6505-01-618-5356
Alternate Parts: 449511, 6505NCM139136, NDC61958070101, NDC61958-0701-01, 6505-01-618-5356, 01-618-5356, 6505016185356, 016185356
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-618-5356
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 449511 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM139136 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC61958-0701-01 | 0SFJ8 | GILEAD SCIENCES, INC. |
Technical Data | NSN 6505-01-618-5356
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | 200MG EMTRICITABINE AND 300MG OF TENOFOVIR DISOPROXIL FUMARATE; 30 TABLETS PER BOTTLE; TAKEN ORALLY; COMBINATION OF EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE IS INDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS (SUCH AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OR PROTEASE INHIBITORS) FOR THE TREATMENT OF HIV-1 INFECTION IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER; ALSO APPROVED FOR USE IN COMBINATION WITH SAFER SEX PRACTICES FOR PRE-EXPOSURE PROPHYLAXIS (PREP), TO REDUCE THE RISK OF SEXUALLY ACQUIRED HIV-1 INFECTION IN ADULTS AT HIGH RISK |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | EMTRICITABINE/TENFOVIR (200MG/300MG) TABS 30S |